You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hemosiderosis

Showing 26 - 50 of 72
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Evaluate Cognitive and Brain Function of ß-thalassemia Patients.

Unknown status
  • Thalassemia
  • Brain Function (Measured by ERP Level)
    • Afula, Israel
      Haemek Medical Center
    Oct 30, 2019

    Nutritional Status in Thalassemia Major Assiut Children Hospital

    Completed
    • Thalassemia Major
      • Assiut, Egypt
        Asmaa Refaat Abdelmonem
      Jul 28, 2020

      Choroidal Thickness in Beta-thalassemia Patients

      Completed
      • Beta-Thalassemia
      • EDI-OCT
      • Patras, Achaea, Greece
        Department of Ophthalmology, General University Hospital of Patr
      Jun 24, 2020

      Myocardial Iron Overload, HFE-Associated Hereditary Hemochromatosis Trial in Rennes (3Tesla cardiac MRI, Electrocardiogram

      Completed
      • Myocardial Iron Overload
      • HFE-Associated Hereditary Hemochromatosis
      • 3Tesla cardiac MRI
      • +6 more
      • Rennes, France
        Rennes University Hospital
      Oct 18, 2017

      Cystatin c and Beta 2 Microglobulin in Thalassemic Children.

      Unknown status
      • Blood Disease
      • Cystatin c and beta 2 microglobulin kits
      • (no location specified)
      Mar 18, 2019

      Beta-Thalassemia, Hemosiderosis Trial in Worldwide (deferasirox)

      Completed
      • Beta-Thalassemia
      • Hemosiderosis
      • Cairo, Egypt
      • +4 more
      Feb 28, 2017

      Thalassemia, Iron Overload, Hemochromatosis Trial run by the NIDDK (Nifedipine, Phlebotomy, Urinalysis)

      Completed
      • Thalassemia
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jun 30, 2017

      Idiopathic Pulmonary Hemosiderosis Trial (Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis)

      Unknown status
      • Idiopathic Pulmonary Hemosiderosis
      • Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis
      • (no location specified)
      Dec 6, 2016

      Beta-thalassemia, MDS, Fanconi Syndrome Trial in United States (Deferasirox)

      Completed
      • Beta-thalassemia
      • +4 more
      • Oakland, California
      • +5 more
      Aug 17, 2017

      Anemia, Sickle Cell, Transfusion Hemosiderosis Trial in Los Angeles (deferasirox)

      Terminated
      Has Results
      • Anemia, Sickle Cell
      • Transfusion Hemosiderosis
      • Los Angeles, California
        Childrens Hospital Los Angeles
      Dec 15, 2016

      Respiratory Variations For Assessing Blood Withdrawal

      Completed
      • Genetic Hemochromatosis
      • echography
      • Lille, France
        Hôpital Roger Salengro, CHRU de Lille
      Feb 27, 2017

      Beta Thalassemia Major Anemia Trial in Cairo. (Metformin)

      Unknown status
      • Beta Thalassemia Major Anemia
      • Cairo., Egypt
      • +1 more
      Jul 16, 2018

      ß Thalassemia Carriers by Red Cell Parameters Obtained From H2

      Unknown status
      • Thalassemia
      • Iron Deficiency
      • Observation of results from laboratory tests
      • Afula, Israel
        Pediatric Hematology Unit - HaEmek Medical Center
      Oct 30, 2019

      MDS, Hemosiderosis Trial in Italy (Deferasirox)

      Completed
      • Myelodysplastic Syndromes
      • Hemosiderosis
      • Alessandria, Italy
      • +16 more
      Nov 21, 2016

      Hemochromatosis, MDS Trial in Bergen (Deferasirox, Venesection)

      Terminated
      • Hemochromatosis
      • Myelodysplastic Syndromes
      • Bergen, Norway
        Haukeland University Hospital, Clinical Trial Unit
      Jan 20, 2017

      MDS (MDS), Quality of Life, Red Blood Cell (RBC) Transfusions Trial in Hamilton, Toronto (Red Blood Cell Transfusions)

      Unknown status
      • Myelodysplastic Syndromes (MDS)
      • +2 more
      • Red Blood Cell Transfusions
      • Hamilton, Ontario, Canada
      • +2 more
      Apr 24, 2018

      Anemia, Sickle Cell Trial in United States (ICL670, deferoxamine)

      Completed
      • Anemia, Sickle Cell
      • ICL670, deferoxamine
      • Mobile, Alabama
      • +33 more
      Aug 18, 2017

      Myelodysplastic Syndrome With Low-grade Lesions, Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Tel Hashomer

      Completed
      • Myelodysplastic Syndrome With Low-grade Lesions
      • Iron Overload Due to Repeated Red Blood Cell Transfusions
      • Tel Hashomer, Israel
        Chim Sheba Medical Center
      Oct 30, 2018

      Postmenopausal Osteoporosis Trial in Suzhou (Deferasirox and calcium-vitamin D3, Calcium-vitamin D3)

      Unknown status
      • Postmenopausal Osteoporosis
      • Deferasirox and calcium-vitamin D3
      • Calcium-vitamin D3
      • Suzhou, Jiangsu, China
        Second Affiliated Hospital of Soochow University
      May 13, 2018

      Hemochromatosis and Iron Overload Screening Study (HEIRS)

      Completed
      • Blood Disease
      • +2 more
        • (no location specified)
        Apr 13, 2016

        Satisfaction in ß-Thalassemia Patients Receiving Deferasirox

        Unknown status
        • β-thalassemia
        • The Medical Outcomes Short-Form 36-Item Health Survey (SF-36v2) It
        • Assiut, Egypt
          Assiut University Hospital
        Nov 27, 2017

        Statistical Basis for Hemochromatosis Screening

        Completed
        • Blood Disease
        • Hemochromatosis
          • (no location specified)
          Feb 17, 2016

          MDS, Transfusion Dependent Iron Overload Trial in Berlin (ICL670/Deferasirox)

          Completed
          • Myelodysplastic Syndromes
          • Transfusion Dependent Iron Overload
          • Berlin, Germany
            Novartis Investigative Site
          May 30, 2017

          Hemochromatosis--Genetic Prevalence and Penetrance

          Completed
          • Blood Disease
          • Hemochromatosis
            • (no location specified)
            Jan 14, 2016

            Anemia, Aplastic, Amegakaryocytic Thrombocytopenia, Diamond-Blackfan Anemia Trial in Memphis (Allogeneic stem cell transplant)

            Completed
            Has Results
            • Anemia, Aplastic
            • +3 more
            • Allogeneic stem cell transplant
            • Memphis, Tennessee
              St. Jude Children's Research Hospital
            Apr 24, 2017